| Ytd | -41.13% | |
| 1y | -89.03% |
| Open | 0.73 | Prev Close | 0.68 | Low | 0.65 | High | 0.73 | Mkt Cap | 32.08M |
| Vol | 6.96K | Avg Vol | 89.07K | EPS | -0.22 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.86 | 200-d Avg | 1.67 | 1yr Est | 0.00 |
Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market
The Notification Letter does not impact the Company's listing on the Nasdaq Capital Market at th